|
⚲
|
| Keyboard |
| Sable Carole
✚
|
|
|---|---|
| CIK # | 0001604066 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001604066] | |
| 4 | [0001604066] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sable Carole | |
| Vitae Pharmaceuticals Inc | |
| Scynexis Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vitae Pharmaceuticals Inc VTAE
Stock Option (Right to Buy) · derivative
|
2016-10-25 | Disposed to issuer | 150,000 | $10.49 | 1,573,500 |
|
Vitae Pharmaceuticals Inc VTAE
Employee Stock Option (Right to Buy) · derivative
|
2016-06-06 | Grant | 150,000 | $0.00 | |
|
Scynexis Inc SCYX
Stock Option (right to buy) · derivative
|
2014-06-18 | Disposed to issuer | 46,636 | ||
|
Scynexis Inc SCYX
Stock Option (right to buy) · derivative
|
2014-06-18 | Grant | 46,636 | ||
|
Scynexis Inc SCYX
Stock Option (right to buy) · derivative
|
2014-06-18 | Grant | 26,970 | $0.00 |